Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110877
Status:
COMPLETED
Last Update Posted:
2015-07-03
First Post:
2005-05-13
Brief Title:
TMC114-C214 Trial of TMC114 Administered With Low Dose Ritonavir RTV in HIV-1 Infected Treatment Experienced Patients
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland
Organization Data
Organization:
Tibotec Pharmaceuticals Ireland
Class:
INDUSTRY
Study ID:
CR002794
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tibotec Pharmaceuticals Ireland
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None